Anurag Mehta Selected Research

Anurag Mehta Research Topics

Disease

36	Neoplasms (Cancer) 03/2024 - 04/2006
25	Cardiovascular Diseases (Cardiovascular Disease) 06/2024 - 01/2020
11	Breast Neoplasms (Breast Cancer) 07/2022 - 01/2015
11	Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung) 06/2022 - 07/2014
9	Carcinoma (Carcinomatosis) 05/2024 - 01/2014
9	Adenocarcinoma of Lung 10/2023 - 01/2013
6	Neoplasm Metastasis (Metastasis) 02/2024 - 12/2015
6	COVID-19 01/2022 - 04/2020
5	Atherosclerosis 02/2024 - 01/2018
5	Adenocarcinoma 01/2024 - 10/2015
5	Coronary Artery Disease (Coronary Atherosclerosis) 01/2023 - 01/2019
5	Lung Neoplasms (Lung Cancer) 01/2022 - 01/2018
4	Obesity 02/2024 - 01/2023
4	Inflammation (Inflammations) 12/2023 - 01/2018
4	Coronary Disease (Coronary Heart Disease) 03/2023 - 01/2019
4	Hypertension (High Blood Pressure) 01/2023 - 01/2021
3	Weight Loss (Weight Reduction) 02/2024 - 01/2023
3	Infections 07/2023 - 04/2006
3	Diabetes Mellitus 01/2023 - 01/2019
3	Triple Negative Breast Neoplasms 01/2020 - 01/2014
2	Dyslipidemias (Dyslipidemia) 03/2024 - 11/2023
2	Overweight 02/2024 - 01/2023
2	Colonic Neoplasms (Colon Cancer) 02/2024 - 10/2023
2	Heart Failure 01/2024 - 01/2023
2	Non-alcoholic Fatty Liver Disease 11/2023 - 11/2023
2	Uterine Cervical Neoplasms (Cancer of the Cervix) 08/2022 - 01/2021
2	Diffuse Large B-Cell Lymphoma (Lymphoma, Large Cell, Diffuse) 07/2022 - 06/2021
2	Colorectal Neoplasms (Colorectal Cancer) 04/2022 - 12/2018
2	Squamous Cell Carcinoma of Head and Neck 01/2022 - 11/2015
2	Myocardial Infarction 11/2021 - 11/2020
2	Prostatic Neoplasms (Prostate Cancer) 08/2021 - 07/2015
2	Stroke (Strokes) 11/2020 - 01/2020
2	Anemia 10/2019 - 07/2019
2	Ovarian Neoplasms (Ovarian Cancer) 03/2019 - 01/2018
2	Lactic Acidosis 01/2019 - 11/2018
2	Precursor Cell Lymphoblastic Leukemia-Lymphoma (Acute Lymphoblastic Leukemia) 08/2018 - 01/2018
2	Lymphoma (Lymphomas) 01/2018 - 07/2017
2	Multiple Myeloma 10/2015 - 09/2011
1	Aortic Valve Stenosis (Aortic Stenosis) 05/2024
1	Insulin Resistance 03/2024
1	Fibrosis (Cirrhosis) 03/2024

Drug/Important Bio-Agent (IBA)

17	Biomarkers (Surrogate Marker)IBA 11/2023 - 07/2014
9	Lipoprotein(a)IBA 06/2024 - 01/2020
9	ErbB Receptors (EGF Receptor)IBA 05/2024 - 01/2013
9	CalciumIBA 02/2024 - 01/2018
7	LipidsIBA 03/2024 - 01/2019
6	oxidized low density lipoproteinIBA 06/2024 - 01/2020
5	LDL CholesterolIBA 06/2024 - 01/2020
5	Proteins (Proteins, Gene)FDA Link 01/2024 - 07/2018
4	Anaplastic Lymphoma KinaseIBA 06/2022 - 04/2013
4	DNA (Deoxyribonucleic Acid)IBA 11/2020 - 09/2016
3	RNA (Ribonucleic Acid)IBA 02/2024 - 07/2017
3	Formaldehyde (Formol)FDA Link 01/2024 - 01/2014
3	ParaffinIBA 01/2024 - 01/2014
3	HDL CholesterolIBA 11/2023 - 01/2020
3	Phosphotransferases (Kinase)IBA 10/2023 - 01/2018
3	AntigensIBA 07/2023 - 06/2021
3	Tyrosine Kinase InhibitorsIBA 06/2022 - 01/2020
3	Keratins (Keratin)IBA 04/2022 - 03/2017
3	human ERBB2 proteinIBA 01/2022 - 11/2020
3	Cell-Free Nucleic AcidsIBA 12/2021 - 10/2020
3	Hormones (Hormone)IBA 10/2021 - 01/2015
3	CrizotinibIBA 01/2020 - 09/2017
3	Progesterone Receptors (Progesterone Receptor)IBA 01/2015 - 01/2009
2	Lipoproteins (Lipoprotein)IBA 06/2024 - 11/2023
2	Anti-Obesity Agents (Antiobesity Drugs)IBA 02/2024 - 01/2023
2	tirzepatideIBA 02/2024 - 01/2023
2	CateninsIBA 01/2024 - 10/2015
2	Urokinase Plasminogen Activator ReceptorsIBA 12/2023 - 01/2020
2	C-Reactive ProteinIBA 12/2023 - 11/2021
2	ApolipoproteinsIBA 11/2023 - 01/2022
2	CholesterolIBA 07/2023 - 01/2019
2	Nucleic AcidsIBA 07/2023 - 01/2021
2	Angiotensin-Converting Enzyme Inhibitors (ACE Inhibitors)IBA 01/2023 - 01/2022
2	Hydroxymethylglutaryl-CoA Reductase Inhibitors (HMG-CoA Reductase Inhibitors)IBA 01/2023 - 01/2022
2	Salivary Proteins and PeptidesIBA 01/2022 - 03/2019
2	MicroRNAs (MicroRNA)IBA 01/2022 - 01/2020
2	Phenobarbital (Luminal)FDA Link 10/2021 - 04/2019
2	Protein-Tyrosine Kinases (Tyrosine Kinase)IBA 01/2020 - 01/2013
2	Androgen Receptors (Androgen Receptor)IBA 07/2019 - 07/2015
2	Metformin (Glucophage)FDA LinkGeneric 01/2019 - 11/2018
2	Indicators and Reagents (Reagents)IBA 01/2019 - 01/2018
2	Liraglutide FDA Link 01/2019 - 11/2018
2	Hematoxylin (Haematoxylon)IBA 09/2018 - 03/2017
2	Eosine Yellowish-(YS) (Eosin)IBA 09/2018 - 03/2017
2	Trastuzumab (Herceptin)FDA Link 09/2018 - 04/2017
2	Epidermal Growth Factor (EGF)IBA 01/2015 - 01/2014
2	Estrogen ReceptorsIBA 01/2015 - 01/2014
1	Mutant Proteins (Protein, Mutant)IBA 05/2024
1	SMARCB1 ProteinIBA 03/2024
1	Sucrose (Saccharose)IBA 03/2024
1	Fatty Acids (Saturated Fatty Acids)IBA 03/2024
1	Glucagon-Like Peptide 1 (GLP 1)IBA 02/2024

Therapy/Procedure

26	Therapeutics 05/2024 - 01/2009
6	Drug Therapy (Chemotherapy) 06/2021 - 12/2014
4	Radiotherapy 01/2021 - 09/2011
3	Hysterectomy 01/2024 - 07/2011
2	Obesity Management 01/2024 - 09/2023
2	Immunotherapy 01/2021 - 01/2021
1	Secondary Prevention 06/2024